CML: Treatment Advances 2026

Dr. Fadi Haddad from The University of Texas MD Anderson Cancer Center addresses current treatments for chronic myeloid leukemia (CML) and shares what new treatments are on the horizon. This program was presented as part of the New & Emerging Treatments webinar series, hosted annually by the Leukemia Research Foundation for leukemia patients, caregivers, family members and healthcare professionals. ‪@Fadihaddadmd‬